Skip to main content
. 2022 Feb 2;12:1810. doi: 10.1038/s41598-022-05951-z

Table 2.

Hospitalizations for heart failure/cardiomyopathy, and deaths during study period.

1-year follow-up Whole study period
Case n (%) Control n (%) Case n (%) Control n (%)
HF/DCM
Whole period 554 (6.4) 115 (0.7) 805 (9.3) 644 (3.9)
2000–2004 181 (7.1) 59 (1.2) 322 (12.6) 394 (8.2)
2005–2009 178 (6.5) 38 (0.7) 255 (9.3) 191 (3.6)
2010–2014 195 (5.8) 18 (0.3) 228 (6.8) 60 (0.9)
 < 50 years
Whole period 169 (3.1) 0 198 (3.6) 26 (0.2)
2000–2004 43 (3.1) 0 56 (4.1) 16 (0.6)
2005–2009 56 (3.1) 0 64 (3.6) 8 (0.2)
2010–2014 70 (2.9) 0 78 (3.3) 2 (0.0)
 ≥ 50 years
Whole period 385 (12.2) 115 (2.1) 607 (19.2) 618 (11.0)
2000–2004 138 (11.6) 59 (2.9) 266 (22.3) 377 (18.3)
2005–2009 122 (12.5) 38 (2.2) 191 (19.5) 183 (10.4)
2010–2014 125 (12.7) 18 (1.0) 150 (15.2) 58 (3.2)
Mortality
Whole period 705 (8.1) 330 (2.0) 1694 (19.5) 2067 (12.4)
2000–2004 350 (13.7) 191 (4.0) 936 (36.6) 1305 (27.3)
2005–2009 188 (6.8) 87 (1.6) 468 (17.0) 571 (10.8)
2010–2014 167 (5.0) 52 (0.8) 290 (8.6) 191 (2.9)
 < 50 years
Whole period 50 (0.9) 23 (0.2) 115 (2.1) 145 (1.3)
2000–2004 14 (1.0) 10 (0.4) 46 (3.4) 82 (3.0)
2005–2009 14 (0.8) 8 (0.2) 30 (1.7) 47 (1.3)
2010–2014 22 (0.9) 5 (0.1) 39 (1.6) 16 (0.3)
 ≥ 50 years
Whole period 655 (20.8) 307 (5.5) 1579 (50.1) 1922 (34.2)
2000–2004 336 (28.2) 181 (8.8) 890 (74.7) 1223 (59.4)
2005–2009 174 (17.8) 79 (4.5) 438 (44.8) 524 (29.8)
2010–2014 145 (14.7) 47 (2.6) 251 (25.5) 175 (9.7)

HF heart failure, DCM dilated cardiomyopathy.